Alteplase for stroke: money and optimistic claims buttress the "brain attack" campaign.
Lenzer
Jeanne
J
Oak Ridge Journalism, Ellenville, NY 12428, USA. Jlenzer1@csi.com
D000572:American Heart Association; D035843:Biomedical Research; D002986:Clinical Trials as Topic; D016265:Conflict of Interest; D004345:Drug Industry; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D005378:Financial Support; D037921:Gift Giving; D006801:Humans; D009939:Organizations, Nonprofit; D010960:Plasminogen Activators / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic / Q000592:standards; D012955:Societies, Medical; D020521:Stroke / Q000188:drug therapy*; D015912:Thrombolytic Therapy / Q000379:methods / Q000592:standards*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D014481:United States
D005343:Fibrinolytic Agents; D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator